DocDollars

Abiomed

MA · United States · Reporting entity ID 100000010740

Total reported 2019–2025
$50.3M
#175 of 2,960 reporting companies — 0.1% of all reported industry payments
$44.8M in general payments across 231,234 records, plus $5.53M in research funding across 1,374 records.

How it breaks down

General payments $44,777,271
Research funding $5,530,895

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Abiomed reported $50.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #175 of 2,960 reporting companies. 11% of that was research funding and 89% general payments such as consulting, speaking, food and travel. 231,234 general payment records and 1,374 research records were filed.

Common questions about Abiomed

How much has Abiomed paid US doctors?

Abiomed reported $50,308,166 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $44,777,271 in general payments, $5,530,895 in research funding.

How does Abiomed rank among drug and device companies?

It ranks #175 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Abiomed mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.